Vaccine and Treatment Evaluation Units (VTEU)

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2022
  • Known Financial Commitments (USD)

    $5,921,655
  • Funder

    National Institutes of Health (NIH)
  • Principle Investigator

    Pending
  • Research Location

    United States of America, Americas
  • Lead Research Institution

    BAYLOR COLLEGE OF MEDICINE
  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Phase 3 clinical trial

  • Special Interest Tags

    Gender

  • Study Subject

    Clinical

  • Clinical Trial Details

    Clinical Trial, Phase III

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

ABSTRACTThis supplement request is for a Phase 3, randomized, stratified, observer-blind, placebo-controlled study to evaluate the efficacy, safety and immunogenicity, of mRNA-1273 vaccinecompared to placebo in adults 18 years of age and older who have no known history of SARS-CoV-2 infection but whose locations or circumstances put them at appreciable risk of acquiringCOVID-19 and/or SARS-CoV-2 infection. This request also relates to other COVID 19 activities.